Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Breast Cancer: More Breakthroughs and an Embarrassment of Riches

Griggs Jennifer J.; Wolff Antonio C.

首页> 外文期刊>Journal of Clinical Oncology >Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Breast Cancer: More Breakthroughs and an Embarrassment of Riches

【24h】

Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Breast Cancer: More Breakthroughs and an Embarrassment of Riches

机译：细胞周期蛋白依赖性激酶4/6抑制剂治疗乳腺癌：更突破和富裕的尴尬

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Clinical Oncology》 |2017年第25期|共4页
作者
Griggs Jennifer J.; Wolff Antonio C.;
展开▼
作者单位

Univ Michigan Ctr Canc Ann Arbor MI 48109 USA;

Johns Hopkins Kimmel Comprehens Canc Ctr Baltimore MD USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Breast Cancer: More Breakthroughs and an Embarrassment of Riches [J] . Griggs Jennifer J., Wolff Antonio C. Journal of Clinical Oncology . 2017,第25期

机译：细胞周期蛋白依赖性激酶4/6抑制剂治疗乳腺癌：更突破和富裕的尴尬
2. Penta-O-galloyl-β-D-glucose induces G₁arrest and DNA replicative S-phase arrest independently of P21 cyclin-dependent kinase inhibitor 1A, P27 cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally acti [J] . Yubo Chai, Hyo-Jeong Lee, Ahmad Ali Shaik, Breast Cancer Research . 2010,第5期

机译：Penta-O-galloyl-β-D-葡萄糖诱导人类独立于P21细胞周期蛋白依赖性激酶抑制剂1A，P27细胞周期蛋白依赖性激酶抑制剂1B和P53的G _{1 逮捕和DNA复制性S期阻滞乳腺癌细胞并且是口服活性}
3. Protein Phosphatase 1H, Cyclin-Dependent Kinase Inhibitor p27, and Cyclin-Dependent Kinase 2 in Paclitaxel Resistance for Triple Negative Breast Cancers [J] . Saem Hur, Ju Hee Kim, Jihui Yun, Journal of Breast Cancer . 2020,第2期

机译：蛋白质磷酸酶1H，细胞周期蛋白依赖性激酶抑制剂P27和Cyclin依赖性激酶2在三重阴性乳腺癌的紫杉醇抗性中
4. Utilization of Flavonoid Compounds as HER2 Tyrosine Kinase Inhibitor in Breast Cancer Using Fragment-Based Drug Design [C] . Vincent Jonathan Fleming, Mutiara Saragih, Usman Sumo Friend Tambunan International Conference on Science and Technology . 2020

机译：使用碎片的药物设计在乳腺癌中用黄酮类化合物作为HER2酪氨酸激酶抑制剂
5. Preclinical evaluation of inhibitors of the phosphatidylinositide 3-kinase/protein kinase B cell survival pathway in the treatment of pancreatic cancer. [D] . Ng, Sylvia Sze Wai. 2002

机译：磷脂酰肌醇3激酶/蛋白激酶B细胞存活途径抑制剂在胰腺癌治疗中的临床前评价。
6. Penta-O-galloyl-β-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of P21 cyclin-dependent kinase inhibitor 1A P27 cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple-negative xenograft growth [O] . Yubo Chai, Hyo-Jeong Lee, Ahmad Ali Shaik, 2010

机译：Penta-O-galloyl-β-D-葡萄糖在人乳腺癌细胞中独立于P21细胞周期蛋白依赖性激酶抑制剂1AP27细胞周期蛋白依赖性激酶抑制剂1B和P53诱导G1阻滞和DNA复制性S期阻滞并具有口服活性三阴性异种移植生长
7. Penta-O-galloyl-β-D-glucose induces G1arrest and DNA replicative S-phase arrest independently of P21 cyclin-dependent kinase inhibitor 1A, P27 cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple-negative xenograft growth [O] . Yubo Chai, Hyo-Jeong Lee, Ahmad Ali Shaik, 2010

机译：Penta-O-galloyl-β-D-葡萄糖在人乳腺癌细胞中独立于P21细胞周期蛋白依赖性激酶抑制剂1A，P27细胞周期蛋白依赖性激酶抑制剂1B和P53诱导G1阻滞和DNA复制性S期阻滞，并且对三联体具有口服活性负异种移植生长

Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Breast Cancer: More Breakthroughs and an Embarrassment of Riches

著录项

相似文献

相关主题

期刊订阅